efavirenz has been researched along with Encephalopathy, Toxic in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (72.73) | 24.3611 |
| 2020's | 3 (27.27) | 2.80 |
| Authors | Studies |
|---|---|
| Albertyn, CH; Brey, N; Decloedt, EH; Esterhuizen, TM; Kellermann, TA; Nightingale, S; Sinxadi, PZ; Taljaard, JJ; van Rensburg, R | 1 |
| Eastman, RW; Lee Pan, EB; Nightingale, S; Ssemmanda, S; Tucker, LM | 1 |
| Allen Reeves, A; Caballero, J; Fuentes, AV; Harrington, C; Mosley Ii, JF; Thomas, JE | 1 |
| Antunes, AMM; Cipriano, M; Diogo, LN; Grilo, NM; João Correia, M; Matilde Marques, M; Miranda, JP; Monteiro, EC; Pereira, SA; Serpa, J | 1 |
| Dalwadi, DA; Harvey, BH; Ozuna, L; Schetz, JA; Viljoen, M | 1 |
| Decloedt, EH; Maartens, G | 1 |
| Ibarra-Barrueta, O; Mayo-Suarez, J; Mora-Atorrasagasti, O; Palacios-Zabalza, I | 1 |
| Bisaso, KR; Ette, EI; Mukonzo, JK | 1 |
| Anagnostopoulos, A; Aouri, M; Barcelo, C; Buclin, T; Cavassini, M; Decosterd, LA; Günthard, HF; Hugues, H; Rotger, M; Telenti, A; Ternon, B; Vernazza, P; Yerly, S | 1 |
| Antunes, AM; Caixas, U; Correia, MJ; Diogo, LN; Grilo, NM; Harjivan, SG; Marques, MM; Monteiro, EC; Pereira, SA; Sequeira, C | 1 |
| Dabaghzadeh, F; Dashti-Khavidaki, S; Ghaeli, P; Khalili, H | 1 |
4 review(s) available for efavirenz and Encephalopathy, Toxic
| Article | Year |
|---|---|
Neurotoxicities in the treatment of HIV between dolutegravir, rilpivirine and dolutegravir/rilpivirine: a meta-analysis.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Depression; Drug Combinations; Heterocyclic Compounds, 3-Ring; HIV Infections; Humans; Neurotoxicity Syndromes; Oxazines; Piperazines; Pyridones; Randomized Controlled Trials as Topic; Rilpivirine | 2021 |
Adverse Neuropsychiatric Events and Recreational Use of Efavirenz and Other HIV-1 Antiretroviral Drugs.
Topics: Alkynes; Animals; Anti-HIV Agents; Benzoxazines; Cyclopropanes; HIV Infections; Humans; Illicit Drugs; Neurotoxicity Syndromes; Reverse Transcriptase Inhibitors | 2018 |
Neuronal toxicity of efavirenz: a systematic review.
Topics: Alkynes; Animals; Benzoxazines; Brain; Calcium; Cognition Disorders; Cyclopropanes; Drug Tolerance; Humans; Neurons; Neurotoxicity Syndromes; Reverse Transcriptase Inhibitors | 2013 |
Potential benefits of cyproheptadine in HIV-positive patients under treatment with antiretroviral drugs including efavirenz.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Cyproheptadine; Drug Interactions; Evidence-Based Medicine; HIV Seropositivity; Humans; Neurotoxicity Syndromes; Serotonin 5-HT2 Receptor Antagonists | 2012 |
7 other study(ies) available for efavirenz and Encephalopathy, Toxic
| Article | Year |
|---|---|
Pharmacogenetics of the Late-Onset Efavirenz Neurotoxicity Syndrome (LENS).
Topics: Adult; Alkynes; Anti-HIV Agents; Arylamine N-Acetyltransferase; Benzoxazines; Cyclopropanes; Cytochrome P-450 CYP2B6; Female; HIV Infections; Humans; Isoniazid; Male; Neurotoxicity Syndromes; Pharmacogenetics; Polymorphism, Single Nucleotide | 2022 |
Electroencephalography as a diagnostic tool for late-onset efavirenz neurotoxicity syndrome.
Topics: Adult; Case-Control Studies; Electroencephalography; Humans; Neurotoxicity Syndromes; Reproducibility of Results; Retrospective Studies | 2023 |
Unmasking efavirenz neurotoxicity: Time matters to the underlying mechanisms.
Topics: Alkynes; Animals; Anti-HIV Agents; Aryl Hydrocarbon Hydroxylases; Benzoxazines; Biotransformation; Cyclopropanes; Cytochrome P-450 CYP2B1; Hippocampus; Liver; Male; Neurotoxicity Syndromes; Prefrontal Cortex; Rats, Wistar; Steroid Hydroxylases; Sulfhydryl Compounds | 2017 |
Effect of concomitant use of montelukast and efavirenz on neuropsychiatric adverse events.
Topics: Acetates; Adult; Alkynes; Anti-Asthmatic Agents; Anti-HIV Agents; Asthma; Benzoxazines; Cyclopropanes; Drug Interactions; Female; HIV Infections; Humans; Neurotoxicity Syndromes; Quinolines; Sulfides | 2014 |
Markov model for characterizing neuropsychologic impairment and Monte Carlo simulation for optimizing efavirenz therapy.
Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Dose-Response Relationship, Drug; Female; HIV Infections; Humans; Male; Markov Chains; Models, Biological; Monte Carlo Method; Neuropsychological Tests; Neurotoxicity Syndromes; Reverse Transcriptase Inhibitors | 2015 |
In Vivo Profiling and Distribution of Known and Novel Phase I and Phase II Metabolites of Efavirenz in Plasma, Urine, and Cerebrospinal Fluid.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Cytochrome P-450 CYP2A6; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP3A; Genotype; Glucuronides; HIV Infections; Humans; Hydroxylation; Metabolic Detoxication, Phase I; Metabolic Detoxication, Phase II; Metabolomics; Neurotoxicity Syndromes; Phenotype; Reverse Transcriptase Inhibitors; Risk Assessment; Sulfates; Tandem Mass Spectrometry | 2016 |
Efavirenz biotransformation as an up-stream event of mood changes in HIV-infected patients.
Topics: Adult; Alkynes; Anti-HIV Agents; Anxiety; Benzoxazines; Biomarkers, Pharmacological; Biotransformation; Blood-Brain Barrier; Case-Control Studies; CD4 Lymphocyte Count; Cyclopropanes; Drug Monitoring; Drug Therapy, Combination; Feasibility Studies; Glucuronides; HIV Infections; Humans; Male; Metabolic Detoxication, Phase II; Middle Aged; Mood Disorders; Neurotoxicity Syndromes; Prevalence; Reverse Transcriptase Inhibitors | 2016 |